Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

A Pilot Quantitative Evaluation of Early Life Language Development in Fragile X Syndrome.

Reisinger DL, Shaffer RC, Pedapati EV, Dominick KC, Erickson CA.

Brain Sci. 2019 Jan 29;9(2). pii: E27. doi: 10.3390/brainsci9020027.

2.

Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study.

Hong MP, Eckert EM, Pedapati EV, Shaffer RC, Dominick KC, Wink LK, Sweeney JA, Erickson CA.

J Neurodev Disord. 2019 Jan 21;11(1):1. doi: 10.1186/s11689-019-9262-4.

3.

A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder.

Wink LK, Adams R, Horn PS, Tessier CR, Bantel AP, Hong M, Shaffer RC, Pedapati EV, Erickson CA.

J Autism Dev Disord. 2018 Sep;48(9):3051-3060. doi: 10.1007/s10803-018-3562-5.

PMID:
29644582
4.

Online Transcranial Magnetic Stimulation Protocol for Measuring Cortical Physiology Associated with Response Inhibition.

Guthrie MD, Gilbert DL, Huddleston DA, Pedapati EV, Horn PS, Mostofsky SH, Wu SW.

J Vis Exp. 2018 Feb 8;(132). doi: 10.3791/56789.

5.

Risperidone Treatment for Irritability in Fragile X Syndrome.

Dominick KC, Wink LK, Pedapati EV, Shaffer R, Sweeney JA, Erickson CA.

J Child Adolesc Psychopharmacol. 2018 May;28(4):274-278. doi: 10.1089/cap.2017.0057. Epub 2018 Feb 2.

PMID:
29394101
6.

Erratum to: Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.

Ethridge LE, White SP, Mosconi MW, Wang J, Pedapati EV, Erickson CA, Byerly MJ, Sweeney JA.

Mol Autism. 2017 Jul 26;8:38. doi: 10.1186/s13229-017-0150-z. eCollection 2017.

7.

Eye gaze and pupillary response in Angelman syndrome.

Hong MP, Guilfoyle JL, Mooney LN, Wink LK, Pedapati EV, Shaffer RC, Sweeney JA, Erickson CA.

Res Dev Disabil. 2017 Sep;68:88-94. doi: 10.1016/j.ridd.2017.06.011. Epub 2017 Jul 24.

PMID:
28750207
8.

Lurasidone for the treatment of irritability and anger in autism spectrum disorders.

McClellan L, Dominick KC, Pedapati EV, Wink LK, Erickson CA.

Expert Opin Investig Drugs. 2017 Aug;26(8):985-989. doi: 10.1080/13543784.2017.1353600. Epub 2017 Jul 24. Review.

PMID:
28685626
9.

Fragile X targeted pharmacotherapy: lessons learned and future directions.

Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E.

J Neurodev Disord. 2017 Jun 12;9:7. doi: 10.1186/s11689-017-9186-9. eCollection 2017. Review.

10.

Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.

Ethridge LE, White SP, Mosconi MW, Wang J, Pedapati EV, Erickson CA, Byerly MJ, Sweeney JA.

Mol Autism. 2017 Jun 7;8:22. doi: 10.1186/s13229-017-0140-1. eCollection 2017. Erratum in: Mol Autism. 2017 Jul 26;8:38.

11.

Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.

Wink LK, Pedapati EV, Adams R, Erickson CA, Pedersen KA, Morrow EM, Kaplan D, Siegel M; Autism and Developmental Disorders Inpatient Research Collaborative (ADDIRC).

J Autism Dev Disord. 2018 Nov;48(11):3711-3719. doi: 10.1007/s10803-017-3153-x.

PMID:
28516426
12.

Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder.

Wink LK, Adams R, Pedapati EV, Dominick KC, Fox E, Buck C, Erickson CA.

J Autism Dev Disord. 2017 Jul;47(7):2290-2294. doi: 10.1007/s10803-017-3132-2.

PMID:
28447303
13.

A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome.

Wang J, Ethridge LE, Mosconi MW, White SP, Binder DK, Pedapati EV, Erickson CA, Byerly MJ, Sweeney JA.

J Neurodev Disord. 2017 Mar 14;9:11. doi: 10.1186/s11689-017-9191-z. eCollection 2017.

14.

d-Cycloserine enhances durability of social skills training in autism spectrum disorder.

Wink LK, Minshawi NF, Shaffer RC, Plawecki MH, Posey DJ, Horn PS, Adams R, Pedapati EV, Schaefer TL, McDougle CJ, Swiezy NB, Erickson CA.

Mol Autism. 2017 Jan 25;8:2. doi: 10.1186/s13229-017-0116-1. eCollection 2017.

15.

Brief Report: Diminished Gaze Preference for Dynamic Social Interaction Scenes in Youth with Autism Spectrum Disorders.

Shaffer RC, Pedapati EV, Shic F, Gaietto K, Bowers K, Wink LK, Erickson CA.

J Autism Dev Disord. 2017 Feb;47(2):506-513. doi: 10.1007/s10803-016-2975-2.

PMID:
27878742
16.

Characterization of autism spectrum disorder with spontaneous hemodynamic activity.

Li J, Qiu L, Xu L, Pedapati EV, Erickson CA, Sunar U.

Biomed Opt Express. 2016 Sep 6;7(10):3871-3881. eCollection 2016 Oct 1.

17.

Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autism.

Erickson CA, Ray B, Wink LK, Bayon BL, Pedapati EV, Shaffer R, Schaefer TL, Lahiri DK.

J Psychiatr Res. 2017 Jan;84:153-160. doi: 10.1016/j.jpsychires.2016.09.003. Epub 2016 Sep 9.

18.

Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder.

Yoon Y, Wink LK, Pedapati EV, Horn PS, Erickson CA.

J Child Adolesc Psychopharmacol. 2016 Nov;26(9):822-827. Epub 2016 Jul 7.

PMID:
27389348
19.

Aggression in autism spectrum disorder: presentation and treatment options.

Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA.

Neuropsychiatr Dis Treat. 2016 Jun 23;12:1525-38. doi: 10.2147/NDT.S84585. eCollection 2016. Review.

20.

Analysis of peripheral amyloid precursor protein in Angelman Syndrome.

Erickson CA, Wink LK, Baindu B, Ray B, Schaefer TL, Pedapati EV, Lahiri DK.

Am J Med Genet A. 2016 Sep;170(9):2334-7. doi: 10.1002/ajmg.a.37811. Epub 2016 Jun 21.

PMID:
27327493

Supplemental Content

Loading ...
Support Center